Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3206 participants.
Also called NCT01035450
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 3,206 participants
- Sponsor
- Registry
-
NCT01035450
-
- Other papers using this trial's data
- 7-Year Outcomes of a Randomized Trial Comparing the First-Generation Sirolimus-Eluting Stent Versus the New-Generation Everolimus-Eluting Stent: The RESET Trial
- Long-term clinical outcomes after everolimus- and sirolimus-eluting coronary stent implantation: final 3-year follow-up of the Randomized Evaluation of Sirolimus-Eluting Versus Everolimus-Eluting Stent Trial
- Ten-year clinical outcomes from a randomized trial comparing new-generation everolimus-eluting stent versus first-generation Sirolimus-eluting stent: Results from the RESET extended study
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Japan
- Registry status
- Completed
Technical summary
Registry record NCT01035450. Randomized; no masking; primary purpose treatment. Start 2010-02 (registry gives no type); primary completion 2014-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial
- Acronym
- RESET
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Everolimus-eluting stent
- Intervention (Device)
- Sirolimus-eluting stent
- Lead sponsor
- Takeshi Morimoto
Record details
- Record id
cardio:ct-nct01035450- Content hash
306fceac8e41aefee2006b253a953bf8a0675306968140c7019bed4e7b0d4a56